edema and ultrafiltration in ecls patients€¦ · 3/5/2019 · 1) edema (adults) averages +14% of...
TRANSCRIPT
Edema and Ultrafiltration in ECLS Patients
THE MISSOURI PERFUSION SOCIETY 23rd Annual Scientific Meeting Embassy Suites Country Club Plaza Kansas City,
Missouri June 1 & 2, 2018
Gary Grist RN CCP Emeritus
No disclosures
Grist 2
Hemoconcentrators
Grist 3
RESIDUAL OXYGENATOR BLOOD VOLUME:THEN AND NOW
BUBBLE OXYGENATOR WITHOUT
ULTRAFILTRATION: RESIDUAL
VOLUME ~ 1000 MLS
HOLLOW FIBER MEMBRANE
OXYGENATOR WITH
ULTRAFILTRATION: RESIDUAL
VOLUME ~ 10 MLS
4
Likely causes, frequent consequences and preventative treatments for edema in ECLS patients
Likely Causes
Frequent Consequences
Preventative Treatments
1. Congestive heart failure 2. Preoperative fluid resuscitation
3. Crystalloid hemodilution
4. Hypothermia
5. Altered blood flow
6. Vascular tone changes
7. Pediatrics
a. low body weight
b. immaturity
8. Systemic Inflammatory response
syndrome
a. increased foreign
surface exposure b. increased CPB time
c. increased capillary
permeability
1) Edema (adults) averages +14% of
body weight
2) Edema (neonates)
37-54% incidence
a) delayed chest
closure
3) Increased blood
transfusion
4) Increased length of
stay
5) Impaired tissue
oxygenation 6) Prolonged ventilation
7) Need for circulatory
support
8) Myocardial edema
9) Pulmonary edema
10) Organ dysfunction
11) Acute respiratory
distress syndrome
1) Reduce prime volume a) retrograde autologous
priming
b) mini circuits
2) Increase the oncotic/osmotic
pressure in the blood
a) mannitol
b) albumin
c) plasma protein fraction
d) fresh frozen plasma
e) dextran
f) hydroxyethyl starch
g) hypertonic saline 3) Steroids to reduce
inflammatory response
a) dexamethasone
b) methylprednisolone
4) Continuous ultrafiltration
5) Modified ultrafiltration
6) Vasopressors
7) Diuretics
Information derived from Hirleman and Larson, 2008
Perioperative Fluid BalanceAnd Survival
D. Chappell et al. Anesthesiology, V 109, No 4, Oct 2008
A. Lowell et al. Crit Care Med. 1990 Jul;18(7):728-33
n = 48 surgical ICU patients
• Native Reservoir
• Adult TBW 58%
– 19% ECW
• 4% intravascular (plasma)
• 15% interstitial.
• Neonates TBW 79%– 44% ECW
• 6% intravascular (plasma)
• 38% interstitial
• Interstitial fluid protects against dehydration/acute blood loss
• Loss of native reservoir fluid > hypotension/organ failure.– Heat stroke
• Ready Reservoir
• 33% of all peds cardiac pts have CHF
• Many adult pts coming to surgery have excess fluid from CHF.
• All pts coming to OR receive IV rehydration after fasting.
• A few pts have received IV resuscitation prior to surgery.
• Safe to remove ready reservoir fluids to prevent edema.
SYSTEMIC CAPILLARY EDEMA FORMATION DURING RESUSITATION, CPB OR ECMO:
FLUID SETTLES IN THE ORGANS AND PERIPHERY
Angioedema
PULMONARY CAPILLARY EDEMA FORMATION DURING RESUSITATION, CPB OR ECMO: FLUID SETTLES IN THE LUNGS
INTERSTITIAL EDEMA
PVR
RV FILLING PRESSURE
LV PRELOAD
MAP
aADO2
AIRWAY RESISTANCE
PULMONARY COMPLIANCE
ALVEOLAR
CAPILLARY
PLEXUS
ALVEOLAR
CAPILLARY
PLEXUS
Capillary Targets:Continuous ultrafiltration (CUF) during CPB or VA ECMO
Modified ultrafiltration (MUF) after CPB or VV ECMO
9
200 50 50 50
200 -150 800 0
500 800 1200
300 350
500
1500 1000 800 1200
500 -400
100
CPB Fluid Additions Vol (ml) CPB Fluid Deductions Vol (ml)
Starting Level Ending Level Starting Level
PERFUSION INTAKE & OUTPUT (I & O)
MUF Fluid Additions Vol (ml) MUF Fluid Deductions Vol (ml)
Ending Level
Cardioplegia crystalloid Circuit volume bal Crystalloid Circuit volume bal
Crystalloid Ultrafiltration Ultrafiltration
Blood Urine
Estimated irrigation
Total Additions = Total Deductions = Total Additions = Total Deductions =
Additions less deductions during CPB = Additions less deductions during MUF =
( 'PERFUSION I & O' DOES NOT QUANTIFY PERIOPERATIVE PATIENT FLUID BALANCE ) PERFUSION I & O =
R#: Allergy: Date: Case#
ACCT#: MR#: SEX: Age: 0.0 DAYS Ht(cm): Wt(kg): BSA (M2): 0.00
PATIENT NAME Admit Date: WBC: H/H: Platelets: PT/APTT: Sodium:
INSURANCE: DOB: Potassium: Anion gap: Glucose: BUN: Creatinine: Calcium:
PCP: Age(YR): -
REFERRING: Age(MO): -
Age(DAYS): -
0 0 Time Product Type Unit No. Vol (ml)
200 50 50 50
200 -150 800 0
500 800 1200
300 350
Time Unit No. Vol (ml) 500
Vol (ml) n/a 1500 1000 800 1200
n/a 500 -400
0:00 100
Total = 0:00 Start *Temp º C End *Temp º C Time Vol (ml) ml/min mmHg Temp º C
On 1000 Time Amount Time Amount Time Amount Time Amount Time Amount Time Amount
Off
On
Off 0:00
On Start *Temp º C End *Temp º C
Off Total = 1000 200
On Time
Off # Total = 0 Total = 0 Total = 0 Total = 0 Total = 0
Line Arterial CVP L/min FiO2 cc/min mmHg H2O Arterial Venous pH pCO2 pO2 BE Hct % O2 Sat K+
iCa++ Glucose ACT
Comments:
Date: Date:
Legend: ACT: activated clotting time measured in seconds, CPB: cardiopulmonary bypass, H/E: heat exchanger, MUF: modified ultrafiltration, PAN03 or PAN06: model number for ultrafiltrator.
Protamine admin time
HYPOTHERMIC ARREST TIME =
* See EVENTS & STATUS: TEMPERATURES
for site of patient temperature monitoring
Flow
ml/min
SWEEP GAS
s/p protamine ACT
Perfusion Assistant Signature:
Time Event
Prime Drug Addtions Amount
PRIME COMMPONENTS
Calc. Heparin units =
Perfusionist#2:
Perfusion Assist. #2Perfusion Assist. #1
Preop Lab Date:
Cath/ECHO/Dx:
Product
BLOOD PRODUCTS ADDED TO PUMP
CPB Fluid Additions Vol (ml) CPB Fluid Deductions Vol (ml)
PATIENT ANTICOAGULATION
Protamine (mg) dose
Heparin admin time
Heparin (units) dose
Final s/p heparin ACT
s/p heparin ACT @ CPB
Prime Fluid Additions Vol (ml) Starting Level
CO2 GAS
BLOOD DRAWN FROM PATIENT OR PUMPCANNULAE
Albumin 25%
Blood
Perfusionist Signature:
CPB/Perfusion Record 7169-006 MR 09/03
CPB TIME
Drug volume
Fluid removed
from prime
Sodium bicarbonate (mEq)
Heparin (units)Crystalloid
Total Prime (ml) =
Procedure:
Ending Level
Single Dose Given
Starting Level
PERFUSION INTAKE & OUTPUT (I & O)
MUF Fluid Additions Vol (ml) MUF Fluid Deductions Vol (ml)
Patients's Blood Type:
Surgeon:
Anesthesiologist:
Pump Flow (ml/min): 0
Perfusionist#1:
In-line
%SVO2
TEMPERATURES ºCPRESSURES mmHg
CIRCUIT COMPONENTS
CROSS CLAMP TIME =
DEFIB
CARDIOPLEGIA ( Temp °C =cardioplegia temperature)
Crystalloid only =
Isoflurane (%)
Ending Level
Cardioplegia crystalloid Circuit volume bal Crystalloid Circuit volume bal
Crystalloid Ultrafiltration Ultrafiltration
Blood Urine
Estimated irrigation
Total Additions = Total Deductions = Total Additions = Total Deductions =
Additions less deductions during CPB = Additions less deductions during MUF =
( 'PERFUSION I & O' DOES NOT QUANTIFY PERIOPERATIVE PATIENT FLUID BALANCE ) PERFUSION I & O =
DRUG ADDITIONS
Single Dose Given
LAB VALUES & RANGES
EVENTS & STATUS
MUF FLUID BALANCE VS.
HEMATOCRIT INCREASE
0
2
4
6
8
10
-70 -60 -50 -40 -30 -20 -10 0
NET FLUID BALANCE MLS/KG
% H
EM
AT
OC
RIT
IN
CR
EA
SE
ULTRAFILTRATION OR DIURESIS REVERSES EDEMATO IMPROVE TISSUE OXYGENATION: SYSTEMIC CAPILLARIES
12
FLUID FROM CHF, IV
CRYSTALLOID & PUMP
PRIME SETTLES IN LUNG
DURING CPB OR ECMO,
DECREASING PCD
FLUID REMOVED FROM LUNG
DURING MUF OR SCUF
INCREASES PCD
Net fluid balance after
CPB/MUF = - 32 ± 55 ml/kg
PULMONARY EDEMA
PVR
RV FILLING PRESSURE
LV PRELOAD
PULMONARY EDEMA
PVR
RV FILLING PRESSURE
LV PRELOAD
aADO2
AIRWAY RESISTANCE
PULMONARY COMPLIANCE
CVP = 16, MAP = 40
aADO2
AIRWAY RESISTANCE
PULMONARY COMPLIANCE
CVP = 8, MAP = 80
ALVEOLAR
CAPILLARY
PLEXUS
ALVEOLAR
CAPILLARY
PLEXUS
Pulmonary Edema Reversal by MUF or SCUFEdema Formation Impairs Heart & Lung Function
Oncotic vs. Osmotic Pressure
• Oncotic (colloid osmotic pressure, COP)
• Pressure exerted by larger molecules (proteins) in plasma
• Osmotic
• Pressure exerted by smaller molecules (glucose, ions) in plasma
Hemodilution AndColloid Oncotic Pressure (COP)
• Hemodilution decreases COP unless albumin or colloid-based volume expanders are added to the prime– Normal COP = 20-30 mmHg– Normal albumin 3-5 gm/dL
• COP causes fluid to move from blood into the extravascular space
• COP causes fluid to move from extravascular space into the blood
• SIRS causes capillary protein leak > edema
Hemodilution AndOsmotic Pressure (Osmolarity)
• Hemodilution does not effect osmolarity– Nml = 275-299 mosmols/L
• Low blood osmolarity moves fluid from blood to extravascular space– LR = 275 mosmols/L– 0.45%NS = 154 mosmols/L– D5W = 250 mosmols/L
• Becomes free water
• High blood osmolarity moves fluid from extravascular space to blood– 0.9%NS = 308 mosmols/L– Plasmalyte 310 mosmols/L
• 2/3 of crystalloid solutions move across capillary > edema
INFANT MUF
PULMONARY
PHYSIOLOGY
Blood proteins in residual
circuit volume are
concentrated and directed
into lungs
ADULT MUF
PULMONARY
PHYSIOLOGY
Mannitol 2 gm/L or
50 mEg/L NaHCO3
into residual circuit
volume and directed
into lungs
FLUID BALANCE VS. MORTALITY80% NEGATIVE BALANCE, 20% POSITIVE BALANCE [n = 1540]
Grist G, Whittaker C, Merrigan K, Fenton J, Worrall E, O'Brien J, Lofland G.The Correlation Of Fluid Balance Changes On Cardiopulmonary Bypass To Mortality In Pediatric And
Congenital Heart Surgery Patients. J Extra Corpor Technol, Dec, 2011;43(4):215–226
FIG 4. CPB PATIENTS: WEIGHT,
NEGATIVE OR POSITIVE FLUID BALANCE CHANGE , AND % MORTALITY
0
5
10
15
20
25
<6 KG n=611 6-12 KG n=476 >12 KG n=453
WEIGHT CATEGORY
% M
OR
TA
LIT
Y NEGATIVE FLUID BALANCE PATIENTS
POSITIVE FLUID BALANCE PATIENTS
p = 0.004
Exp = 2X
p = 0.069
Exp = 3X
p = 0.024
Exp = 4X
19
FLUID BALANCE VS. MORTALITY80% NEGATIVE BALANCE, 20% POSITIVE BALANCE [n = 1540]
Grist G, Whittaker C, Merrigan K, Fenton J, Worrall E, O'Brien J, Lofland G.The Correlation Of Fluid Balance Changes On Cardiopulmonary Bypass To Mortality In Pediatric And
Congenital Heart Surgery Patients. J Extra Corpor Technol, Dec, 2011;43(4):215–226
CPB PATIENTS: FLUID BALANCE CHANGE AT END OF CPB/MUF VS. MORTALITY
* Indicates Percent of Population Occurance, n = 1540
0
2
4
6
8
10
12
14
16
18
20
< -41 -40 TO -21 -20 TO 0 +1 TO +20 +21 TO +40 >+ 41
FLUID BALANCE MLS PER KG
% M
OR
TA
LIT
Y
34%*
20%* 26%*
11%*
6%*
3%*
20
Targeting the Need for CUFDo you need to ultrafiltrate?
Is The Patient Taking Diuretics (CHF)?Do you want to avoid RAP (unstable BP) ?
DRY WT.% CHF FLUID
WT. GAIN
FLUID
OVERLOADWET WT. CPB TIME
CONTINUOUS UF
FLUID REMOVAL
RATE
TOTAL FLUID
REMOVED
FLUID
REMOVED
% NET
FLUID
BALANCE
70 KG 5% 3.5 L 73.5 KG 60 MIN 20 ML/MIN 1.2 L - 17 ML/KG -1.7%
70 KG 5% 3.5 L 73.5 KG 120 MIN 20 ML/MIN 2.4 L - 34 ML/KG - 3.4%
50 KG 5% 2.5 L 53.5 KG 60 MIN 20 ML/MIN 1.2 L - 24 ML/KG - 2.2%
50 KG 5% 2.5 L 53.5 KG 120 MIN 20 ML/MIN 2.4 L - 48 ML/KG - 4.4%
Infant MUF vs. Adult MUF
• Blood passing through the hemoconcentrator develops a high oncotic pressure as excess fluid is removed from it.
• Infant MUF ratio = 1/5 MUF blood to venous return
– 100 cc/min MUF flow : 500 cc/min CO
• Higher oncotic blood going to the right heart and lungs
• Pulmonary water (edema) removed from the lungs
• Improved pulmonary and hemodynamic function
– Typically 5-10% hematocrit increase
– Clotting factors increased w/o increasing blood volume
23
• Blood passing through the hemoconcentrator develops a high oncotic pressure as excess fluid is removed from it.
• 1/20: MUF blood flow / venous return to the lungs– 200 cc/min MUF flow : 4000 cc/min CO
• High oncotic MUF blood diluted by the high volume of right heart blood
• Relatively low oncotic blood goes to the lungs
• No significant oncotic drag to remove water from lung tissue
• Pulmonary benefits negligible
– Typically 1- 4% hematocrit increase
– Clotting factors minimally concentrated• +/- reduced bleeding
Adult MUF
24
• After CPB, patient osmolarity = 300 mosmoles
• Residual circuit volume = 1 L @ 300 mosmoles
• Add 50 mEq/L NaHCO3 or 2 gm/L mannitol to circuit– Increases residual circuit fluid osmolarity to 400 mosmols/L
• 200 mls/min MUF blood (400 mosmols/L) + 4000 mls/min patient blood (300 mosmols/L) passing through the right heart to the lungs
• Pulmonary artery blood osmolarity increases from 300 to 305
• Osmotic drag removes 67 mls/min fluid from lung tissue
• Removes 335 mls from lungs in 5 minutes of MUF
• Also, can add 50% albumin (50-100 mls) to circuit volume.
Adult MUF:
Pulmonary effects can be improved
Circuit Configuration:Cardioplegia, CUF and MUF
Questions